Cargando…
Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants
Kasabach-Merritt phenomenon (KMP) is a life-threatening condition caused by rare vascular tumors. To reduce drug resistance observed in monotherapy of KMP with prednisone, vincristine (VCR) or sirolimus, the present study evaluated the efficacy and safety of triad therapy in the treatment of KMP. A...
Autores principales: | Liu, Qianlong, Xiong, Na, Gong, Xinyuan, Tong, Haochongyang, Tan, Xuanfeng, Guo, Xinkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468795/ https://www.ncbi.nlm.nih.gov/pubmed/36160903 http://dx.doi.org/10.3892/etm.2022.11558 |
Ejemplares similares
-
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon
por: Alaqeel, Alaa M., et al.
Publicado: (2016) -
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
por: Cabrera, Trevor B., et al.
Publicado: (2020) -
Neonatal Kasabach-Merritt phenomenon
por: Yadav, Dinesh, et al.
Publicado: (2011) -
Effective low–dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach–Merritt phenomenon in young infants
por: Harbers, Veroniek E. M., et al.
Publicado: (2022) -
Kaposiform haemangioendothelioma with Kasabach - Merritt phenomenon
por: Jandial, Aditya, et al.
Publicado: (2020)